The coronavirus disease pandemic among adult congenital heart disease patients and the lessons learnt - results of a prospective multicenter european registry
- PMID: 36440468
- PMCID: PMC9678209
- DOI: 10.1016/j.ijcchd.2022.100428
The coronavirus disease pandemic among adult congenital heart disease patients and the lessons learnt - results of a prospective multicenter european registry
Abstract
Background: At the beginning of the COVID-19 pandemic, professionals in charge of particularly vulnerable populations, such as adult congenital heart disease (ACHD) patients, were confronted with difficult decision-making. We aimed to assess changes in risk stratification and outcomes of ACHD patients suffering from COVID-19 between March 2020 and April 2021.
Methods and results: Risk stratification among ACHD experts (before and after the first outcome data were available) was assessed by means of questionnaires. In addition, COVID-19 cases and the corresponding patient characteristics were recorded among participating centres. Predictors for the outcome of interest (complicated disease course) were assessed by means of multivariable logistic regression models calculated with cluster-robust standard errors. When assessing the importance of general and ACHD specific risk factors for a complicated disease course, their overall importance and the corresponding risk perception among ACHD experts decreased over time. Overall, 638 patients (n = 168 during the first wave and n = 470 during the subsequent waves) were included (median age 34 years, 52% women). Main independent predictors for a complicated disease course were male sex, increasing age, a BMI >25 kg/m2, having ≥2 comorbidities, suffering from a cyanotic heart disease or having suffered COVID-19 in the first wave vs. subsequent waves.
Conclusions: Apart from cyanotic heart disease, general risk factors for poor outcome in case of COVID-19 reported in the general population are equally important among ACHD patients. Risk perception among ACHD experts decreased during the course of the pandemic.
Keywords: Adult congenital heart disease; Coronavirus disease 2019; Outcomes; Risk stratification.
© 2022 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Professor Werner Budts reports financial support was provided by Abbott and Occlutech. Following co-authors: Dr. Pastora Gallego, Dr. Magalie Ladouceur, Dr. Massimo Chessa, Professor Werner Budts and Prof. Helmut Baumgartner are Associate Editors and, therefore, members of the Editorial Board of the International Journal of Cardiology Congenital Heart Disease.
Figures


Similar articles
-
Clinical outcome of COVID-19 in patients with adult congenital heart disease.Heart. 2021 Jul 12;107(15):1226-1232. doi: 10.1136/heartjnl-2020-318467. Heart. 2021. PMID: 33685931 Free PMC article.
-
Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts.Open Heart. 2021 Apr;8(1):e001455. doi: 10.1136/openhrt-2020-001455. Open Heart. 2021. PMID: 33883228 Free PMC article.
-
Predictors of COVID-19 outcomes in adult congenital heart disease patients - anatomy versus function.Kardiol Pol. 2022;80(2):151-155. doi: 10.33963/KP.a2021.0176. Epub 2021 Dec 9. Kardiol Pol. 2022. PMID: 34883525
-
Management of acute heart failure in adult patients with congenital heart disease.Heart Fail Rev. 2018 Jan;23(1):1-14. doi: 10.1007/s10741-017-9664-x. Heart Fail Rev. 2018. PMID: 29277859 Review.
-
Metabolic Syndrome in Adult Congenital Heart Disease.Korean Circ J. 2019 Aug;49(8):691-708. doi: 10.4070/kcj.2019.0187. Epub 2019 Jul 5. Korean Circ J. 2019. PMID: 31347322 Free PMC article. Review.
Cited by
-
COVID-19 in Cyanotic Congenital Heart Disease.Can J Infect Dis Med Microbiol. 2023 Apr 18;2023:5561159. doi: 10.1155/2023/5561159. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 37114013 Free PMC article. Review.
References
-
- Zisman L.S., Keller R.S., Weaver B., Lin Q., Speth R., Bristow M.R., et al. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation. 2003;108(14):1707–1712. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous